Skip to main content

Table 2 Weighted prevalence of MetS and component risk factors by sex and ethnicity for Taiwan 2002TwHHH and US NHANES 2001-2002

From: Is impaired energy regulation the core of the metabolic syndrome in various ethnic groups of the USA and Taiwan?

 

Ethnic Groups

Variables

Taiwanese

Non-Hispanic White

Non-Hispanic Black

Mexican- American

All

(N = 5786)

(N = 1077)

(N = 381)

(N = 461)

Abdominal Obesity (NCEP)* ¶

29.8

48.5

46.9

43.1

Abdominal Obesity (IDF)§ ¶

29.8

71.1

62.6

67.8

High Blood Pressure**

29.8

39.7

45.8

21.7

Low HDL†

22.8

33.7

32.0

41.2

High Glucose‡

10.0

36.2

26.7

42.3

High Triglycerides¥

26.3

34.9

18.8

34.8

NCEP MetS

10.8

34.8

28.4

32.8

IDF MetS

8.6

39.9

31.5

35.2

Males

(N = 2827)

(N = 555)

(N = 196)

(N = 249)

Abdominal Obesity (NCEP)* ¶

29.2

39.9

29.3

34.0

Abdominal Obesity (IDF) § ¶

29.2

67.1

49.6

63.0

High Blood Pressure**

35.2

41.9

55.3

38.5

Low HDL†

21.1

32.9

21.7

34.6

High Glucose‡

10.5

46.1

31.3

60.6

High Triglycerides¥

33.2

39.0

23.5

43.0

NCEP MetS

11.2

36.7

26.6

39.5

IDF MetS

9.2

44.6

29.1

42.5

Females

(N = 2959)

(N = 522)

(N = 185)

(N = 212)

Abdominal Obesity (NCEP)* ¶

31.2

51.8

67.5

66.0

Abdominal Obesity (IDF) § ¶

31.2

72.2

83.2

86.1

High Blood Pressure**

25.0

36.1

50.3

32.4

Low HDL†

24.9

35.1

44.1

50.0

High Glucose‡

9.7

25.3

32.0

41.1

High Triglycerides¥

20.5

27.8

16.6

31.6

NCEP MetS

11.0

30.0

37.5

45.7

IDF MetS

8.3

33.2

41.1

47.0

  1. Abbreviations are as footnoted in Table 1.
  2. ¶ Males waist circumference ≥90 cm; females waist circumference ≥80 cm for Taiwanese population;
  3. * NCEP: males waist circumference > 102 cm; female waist circumference > 88 cm;
  4. § IDF: males waist circumference ≥94 cm; females waist circumference ≥80 cm
  5. ** Systolic ≥ 130 mmHg or diastolic ≥85 mmHg or on anti-hypertensive medication
  6. † Males fasting HDL < 40 mg/dL; females fasting HDL < 50 mg/dL
  7. ‡ Fasting glucose ≥110 mg/dL or on glucose-lowering medication
  8. ¥ Triglycerides ≥150 (mg/dl).